Celgene (CELG) Tops Q2 EPS by 5c, Raises FY EPS Guidance
Tweet
Share
E-mail
Get Alerts CELG Hot Sheet
Price: $108.24 --0%
Financial Fact:
Interest expense: -127.8M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Interest expense: -127.8M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
Celgene (NASDAQ: CELG) reported Q2 EPS of $2.16, $0.05 better than the analyst estimate of $2.11. Revenue for the quarter came in at $3.81 billion versus the consensus estimate of $3.7 billion.
GUIDANCE:
Celgene sees FY2018 EPS of $8.70-$8.75, versus the consensus of $8.52. Celgene sees FY2018 revenue of $15 billion, versus the consensus of $14.93 billion.
For earnings history and earnings-related data on Celgene (CELG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Globant (GLOB) Misses Q2 EPS by 10c, Offers Guidance
- Faraday Future Intelligent Electric Inc. (FFAI) Tops Q2 EPS by $20.87, Misses on Revenue
- Xos, Inc (XOS) Tops Q2 EPS by 5c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
